Literature DB >> 4197634

cis-Dichlorodiammineplatinum(II) (NSC-119 875): preclinical toxicologic evaluation of intravenous injection in dogs, monkeys and mice.

U Schaeppi, I A Heyman, R W Fleischman, H Rosenkrantz, V Ilievski, R Phelan, D A Cooney, R D Davis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1973        PMID： 4197634     DOI： 10.1016/s0041-008x(73)80009-2

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN： 0041-008X            Impact factor:   4.219


× No keyword cloud information.
  21 in total

Review 1.  Cisplatin nephrotoxicity. A review.

Authors:  G Daugaard; U Abildgaard
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

2.  Cisplatin nephrotoxicity in male beagle dogs: next-generation protein kidney safety biomarker tissue expression and related changes in urine.

Authors:  J E McDuffie; Y Chen; J Y Ma; S Lee; K M Lynch; D M Hamlin; L Nguyen; M Rizzolio; M Sonee; S Snook
Journal:  Toxicol Res (Camb)       Date:  2016-06-07       Impact factor: 3.524

3.  Pattern of toxicity by titanocene dichloride in mice. Blood and urine chemical parameters.

Authors:  P Köpf-Maier; S Gerlach
Journal:  J Cancer Res Clin Oncol       Date:  1986       Impact factor: 4.553

Review 4.  Antineoplastic drugs: clinical pharmacology and therapeutic use.

Authors:  R A Bender; L A Zwelling; J H Doroshow; G Y Locker; K R Hande; D S Murinson; M Cohen; C E Myers; B A Chabner
Journal:  Drugs       Date:  1978-07       Impact factor: 9.546

5.  Attenuation of cisplatinum-induced nephrotoxicity in the rat by high salt diet, furosemide and acetazolamide.

Authors:  H T Heidemann; J F Gerkens; E K Jackson; R A Branch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-04       Impact factor: 3.000

6.  Attenuation of cisplatin nephrotoxicity by inhibition of soluble epoxide hydrolase.

Authors:  Alan R Parrish; Gang Chen; Robert C Burghardt; Takaho Watanabe; Christophe Morisseau; Bruce D Hammock
Journal:  Cell Biol Toxicol       Date:  2008-04-03       Impact factor: 6.691

7.  Comparative nephrotoxicity of carboplatin and cisplatin in combination with tobramycin.

Authors:  C L Bregman; P D Williams
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

8.  Preclinical toxicity and pharmacology of liposome-entrapped cis-bis-neodecanoato-trans-R,R-1,2-diaminocyclohexane platinum(II).

Authors:  R Perez-Soler; J Lautersztain; L C Stephens; K Wright; A R Khokhar
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

Review 9.  New cisplatin analogues in development. A review.

Authors:  Raymond B Weiss; Michaele C Christian
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

10.  Effect of thymidine on the toxicity and antitumor activity of cis-diamminedichloroplatinum (II).

Authors:  V B Grossie; M Valdivieso; B Drewinko; T L Loo
Journal:  Cancer Chemother Pharmacol       Date:  1984       Impact factor: 3.333
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.